CVS Shucking More Drugs From Its Coverage List

Published November 9, 2012

CVS shucking more drugs from its coverage list

Filed under: drug treatment news

The company is adding 17 drugs to nearly three dozen it already blacklisted, The Wall Street Journal reports. They include Abbott Laboratories' ($ ABT) testosterone treatment AndroGel, Allergan's ($ AGN) glaucoma drug Lumigan, Pfizer's ($ PFE) human …
Read more on FiercePharma

Diabetes Drug Metformin May Lower Risk of Heart Attacks and Strokes

Filed under: drug treatment news

A popular diabetes medication appears to have significant benefits beyond simply treating the disease. Patients taking metformin — which is sold under brand names Glucophage and Fortamet — have a lower risk of heart attacks, strokes and even death …
Read more on DrugWatch.com

BioCryst halts enrollment for flu drug trial [The Herald-Sun, Durham, NC]

Filed under: drug treatment news

09–DURHAM — BioCryst Pharmaceuticals has suspended enrollment in a clinical trial for its most advanced drug candidate — an intravenous treatment for flu. A company spokesman said it's likely the trial will be terminated. The company announced …
Read more on Equities.com